Delivery Order SPE2DR25D2105-SPE2DR26F5VFL
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,738.43 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of January 14, 2026, represents a non-set-aside competitive award and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award is issued under a larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 12, 2026, for the supply of Enbrel 50 mg/mL SureClick auto-injectors valued at $29,386.50. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the contractor's Conshohocken, Pennsylvania location by January 13, 2026. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $36,721.62 for Enbrel 50 mg/mL SureClick auto-injector medication. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,463.86 by the Defense Logistics Agency on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract, issued under firm fixed pricing with no set-aside designation, covers the supply of ENBREL 50 mg/ml SureClick auto-injectors, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $13,880.31 by the Defense Logistics Agency for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed price and represents a non-competitive, non-set-aside award. The place of performance is listed as AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $38,492.04 by the Defense Logistics Agency (DLA) on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract covers the supply of Enbrel 50 mg/ml SureClick auto-injector, a brand-name biologic medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded a $16,367.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on January 9, 2026, with a completion date of January 12, 2026. This non-set-aside award was issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,379.03 by the Defense Logistics Agency (DLA) on November 5, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $48,764.11 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 29, 2025. This competitive award employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $38,597.17 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion scheduled for December 10, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle running through December...
- SPE2DR25D2105Indefinite Delivery Contract
- SPE2DR25D2105-SPE2DR26F5VFLDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,635.32 by the Defense Logistics Agency on January 13, 2026, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 14, 2026. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a subsidiary of Cencora, Inc. (which does business as Amerisourcebergen), the awardee is a critical federal vendor specializing in pharmaceutical distribution and medical supply procurement across multiple therapeutic domains. The Defense Logistics Agency, a component of the Department of Defense, procures medications, vaccines, medical devices, and specialized healthcare commodities through this contract vehicle to support military treatment facilities and veteran healthcare programs globally. Enbrel is a biologic immunosuppressant used to treat inflammatory conditions such as rheumatoid arthritis and is a common pharmaceutical commodity within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.6k | 1/12/26 |